🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great Collins lab journal club today with presentation by MMPainter on #bNabs from this paper nature.com/articles/s4158…

Great start to the first annual Midwest Virology Symopsium! #MidwestVir2019

Excited to hear our own Maria Virgilio 🇺🇦 in this year’s King Talks!

Inspirational! Great job Maria Virgilio 🇺🇦

Check out our latest publication out this week in PNASNews featuring work from Mark Painter!

We are so proud of our own Mark Painter who gave an amazing dissertation defense yesterday! Congratulations Dr Painter!! UMich Imm Grad Prog

Joey Krampen (He/Him) Joey Krampen is a 2nd-year student working in the lab of Kathleen Collins, M.D. Ph.D. He is interested in studying HIV pathology and understanding how immune responses to HIV influence disease progression.

Fantastic talk from our post-baccalaureate PREP scholar, Miguel Disbennett @mdisbennett33 at #cshlretro22 on host mechanisms to silence HIV-1 Michigan Medicine University of Michigan Maria Virgilio 🇺🇦 #umichPREP

In a new Journal of Medicinal Chemistry study, a Michigan Research team reports they have successfully modified a naturally occurring chemical compound, resulting in several advanced lead compounds with anti-HIV activity. lsi.umich.edu/news/2024-03/r… ACS Publications

What a PERFFect day to share our new preprint! With Tsion Abay #BobStickels Meril Takizawa @ChaligneRonan and Ansu Satpathy, we introduce PERFF-seq, a new experimental approach to studying rare cells with scRNA-seq via transcript-specific enrichment. biorxiv.org/content/10.110… 1/n

HIV-1 Vpr combats PU.1-driven antiviral ncbi.nlm.nih.gov/pmc/articles/P… KLCollins Lab Vpr suppresses innate immune response genes in uninfec. bystander cells; virion-assoc. Vpr can degrade PU.1: Vpr counteracts PU.1 in macrophages to blunt antiviral immune responses & promote spread.